Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
121.13
-3.17 (-2.55%)
Streaming Delayed Price
Updated: 2:56 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S ADR
< Previous
1
2
3
4
5
6
7
8
9
...
61
62
Next >
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
July 17, 2024
Roche has a new GLP-1 weight loss drug in the works -- and one very cheap stock.
Via
The Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
July 17, 2024
After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, Pfizer Inc (NYSE: PFE) moved forward with the once-daily version. On...
Via
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest...
Via
Benzinga
$1000 Invested In Novo Nordisk 10 Years Ago Would Be Worth This Much Today
July 17, 2024
Via
Benzinga
Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data
July 17, 2024
Roche released early-stage data on its oral weight-loss drug.
Via
Investor's Business Daily
3 Hot Growth Stocks That Will Make You Forget About AMD
July 16, 2024
There are a number of hot growth stocks out there that can outdo AMD, even after its latest acquisition of Silo AI.
Via
InvestorPlace
Senate To Review Novo Nordisk's Levemir Insulin Discontinuation
July 16, 2024
Novo Nordisk will meet with U.S. Senate aides to discuss the discontinuation of Levemir, its long-acting insulin, amid concerns about manufacturing constraints and patient access. Senators press for...
Via
Benzinga
3 Dow Jones Stocks to Buy at 52-Week Lows in July
July 16, 2024
The Dow Jones has rallied, similar to the other well-known market indices, but not all of its stocks are trading at all-time highs.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
July 15, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
This Analyst Sees Potential Downside In Eli Lilly, Adjusts Model For Acquired IPR&D Charges
July 15, 2024
Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating on Eli Lilly with a price target of $885. Eli Lilly's Q2 FY24 earnings report on August 8 will include a pre-tax IPR&D charge of...
Via
Benzinga
7 Top-Quality Stocks to Buy Now: July 2024
July 15, 2024
With plenty of uncertainties ahead, investors should look for top-quality stocks for the remainder of the year.
Via
InvestorPlace
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
July 15, 2024
Revenue is climbing at these two drug companies -- and the trend should continue.
Via
The Motley Fool
2 Incredibly Cheap Growth Stocks to Buy Now
July 14, 2024
Price is just one factor to consider.
Via
The Motley Fool
Is Eli Lilly a Good Dividend Stock to Buy Now?
July 14, 2024
A leading anti-obesity treatment plus a new Alzheimer's drug could drive profits through the roof.
Via
The Motley Fool
This 1 Piece of Bad News for Novo Nordisk Is Good News for Eli Lilly Stock
July 14, 2024
A new study raises important implications regarding the competitive balance between these two companies.
Via
The Motley Fool
Here's 80 Billion More Reasons to Buy Novo Nordisk Stock
July 13, 2024
Hopes are high about one of its next-gen candidates.
Via
The Motley Fool
The 7 Most Important Stocks to Watch as Q2 Earnings Season Kicks Off
July 13, 2024
Seven Q2 earnings season stocks are powered by catalysts that could have a major impact on their companies fortunes.
Via
InvestorPlace
Did Eli Lilly Just Get a Leg Up on Novo Nordisk?
July 13, 2024
Eli Lilly's latest milestone sets it apart from its rival Novo Nordisk.
Via
The Motley Fool
The Weight Loss Market Can Surge To $400B By 2032, And These Stocks Will Rule It
July 12, 2024
Despite Novo Nordisk's momentum, Eli Lilly seems a better long-term bet. Pfizer could surprise everyone from an undervalued position.
Via
Talk Markets
Novo Nordisk Stock Pops After Weight-Loss Drug Cuts Dementia Risk In Yearlong Study
July 12, 2024
A yearlong study at the University of Oxford suggests GLP-1 drugs could play a role in protecting brain health.
Via
Investor's Business Daily
Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
July 12, 2024
Megacaps and chip plays tumbled Thursday, but mostly still have healthy charts.
Via
Investor's Business Daily
Using Ozempic, Zepbound Or Other Weight Loss Drugs? Inform Doctors Before Anesthesia Or Surgery, European Medicines Agency Issues Advisory
July 12, 2024
EMA advises patients on GLP-1 weight-loss drugs like Wegovy to inform their doctors before surgery due to potential respiratory risks. New warnings to be included in product information to ensure...
Via
Benzinga
3 Global Stocks Worth Buying as America Stumbles
July 12, 2024
It never hurts to diversify your portfolio by adding global stocks, even if America doesn’t fall into the abyss.
Via
InvestorPlace
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
Pharma stocks can be great investments during times of growth and recession, and are made even better if the stock is undervalued.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Novo Nordisk's 'Miracle' Weight Loss Drug Ozempic Linked To 48% Lower Risk Of Dementia, Study Finds
July 12, 2024
Novo Nordisk has found that its diabetes drug, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues.
Via
Benzinga
Eli Lilly, Novo Nordisk Shares Dip As Pfizer Ramps Up Diabetes Drug Competition
July 11, 2024
Shares of Eli Lilly and Co (NYSE: LLY) and Novo Nordisk A/S (NYSE: NVO) are facing declines Thursday, maybe influenced by competitive developments and regulatory updates in the pharmaceutical sector.
Via
Benzinga
Bernie Sanders Targets High Prices of Ozempic and Wegovy In US
July 11, 2024
Senator Bernie Sanders is pushing Novo Nordisk to lower U.S. prices for weight-loss drugs Ozempic and Wegovy, as part of a broader effort to reduce drug costs and expand Medicare price negotiations.
Via
Benzinga
FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
July 11, 2024
The FDA has issued a Complete Response Letter to Novo Nordisk's Biologics License Application for once-weekly basal insulin icodec. Novo Nordisk aims to address the FDA's requests but anticipates...
Via
Benzinga
Exposures
Product Safety
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
July 11, 2024
Vivani Medical plans to start the first clinical study of the NPM-115 program in Australia in Q4 2024. The study will evaluate a 6-month GLP-1 implant for chronic weight management in obese or...
Via
Benzinga
Chipotle Just Did a Stock Split. History Says This Is What Might Happen Next.
July 11, 2024
Big-name stocks that have split their shares in recent years have generally done fairly well afterward.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
61
62
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.